MBX Biosciences (MBX) Operating Leases (2023 - 2026)

MBX Biosciences (MBX) has 4 years of Operating Leases data on file, last reported at $377000.0 in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $377000.0; the trailing twelve-month figure through Mar 2026 stood at $377000.0 (changed N/A YoY), and the FY2025 full-year result was $424000.0, changed N/A from the prior year.
• Operating Leases declined to $377000.0 in Q1 2026, from $424000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $512000.0 in Q2 2025 to a low of $44000.0 in Q3 2024.
• A 4-year average of $332833.3 and a median of $400500.0 in 2025 frame the typical range for Operating Leases.
• Peak annual rise in Operating Leases reached 965.91% in 2025, while the deepest fall reached 965.91% in 2025.
• Tracing MBX's Operating Leases over 4 years: stood at $171000.0 in 2023, then plunged by 74.27% to $44000.0 in 2024, then soared by 863.64% to $424000.0 in 2025, then slipped by 11.08% to $377000.0 in 2026.
• Business Quant data shows MBX's Operating Leases at $377000.0 in Q1 2026, $424000.0 in Q4 2025, and $469000.0 in Q3 2025.